1%

Question 1 of 60

The client is being given Pradaxa (dabigatran). The nurse knows that the mechanism of action of this drug is what?

Rationale:
Pradaxa (dabigatran) directly inhibits thrombin. This action prevents the conversion of fibrinogen to fibrin, thereby reducing thrombus formation and effectively managing conditions related to excessive blood coagulation, such as atrial fibrillation. A: It is an antiplatelet drug. This option mischaracterizes Pradaxa, as antiplatelet drugs primarily prevent platelet aggregation rather than directly targeting thrombin in the coagulation cascade. C: It is a fibrinolytic medication. Fibrinolytic agents work to dissolve existing clots, whereas Pradaxa prevents clot formation by inhibiting thrombin, thus serving a different therapeutic purpose. D: It interferes with the production of clotting factors. This statement is inaccurate since Pradaxa specifically acts on thrombin rather than inhibiting the synthesis of clotting factors in the liver.